Citations (8)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Lori Muffly, Christopher Young, Qi Feng, David Nimke & Bhavik J. Pandya. (2023) Healthcare resource utilization and costs during first salvage therapy for relapsed or refractory acute myeloid leukemia in the United States. Leukemia & Lymphoma 64:11, pages 1832-1839.
Read now
Read now
Jonathan Feld, Douglas Tremblay, Shyamala C. Navada & Lewis R. Silverman. (2023) Ascertaining QUAZARs: slow-motion and light-speed development of oral azacitidine and decitabine. Leukemia & Lymphoma 64:3, pages 525-539.
Read now
Read now
Ranin Soliman, Carl Heneghan, Nancy S. Bolous, Iman Sidhom, Sonia Ahmed, Nia Roberts, Jason Oke & Alaa Elhaddad. (2022) Systematic review of costs and cost-effectiveness of treatment for relapsed/refractory acute leukemia in children and young adults. Expert Review of Hematology 15:4, pages 345-357.
Read now
Read now
Articles from other publishers (5)
Emine Eylem Genç, İrem Sena Saraç, Hayrunnisa Arslan & Ahmet Emre Eşkazan. (2023) Diagnostic and Treatment Obstacles in Acute Myeloid Leukemia: Social, Operational, and Financial. Oncology and Therapy.
Crossref
Crossref
Sravani Kommuru, Sowmya Sagireddy, Adit M Patel, Hruday Raj Thoutam, Saaniya Yasmeen, Amr A Jarrad, Gagan Kaur & Viralkumar Patel. (2022) Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia and Related Hospital Outcomes: A Cross-Sectional Study of US Hospitals. Cureus.
Crossref
Crossref
Michelle ChoiJinlin SongCat N BuiEsprit MaXinglei ChaiLei YinKeith A BettsTatyana KapustyanMelissa MontezThomas William LeBlanc. (2022) Costs per patient achieving remission with venetoclax-based combinations in newly diagnosed patients with acute myeloid leukemia ineligible for intensive induction chemotherapy. Journal of Managed Care & Specialty Pharmacy 28:9, pages 980-988.
Crossref
Crossref
Jannik Stemler, Nick de Jonge, Nicole Skoetz, János Sinkó, Roger J Brüggemann, Alessandro Busca, Ronen Ben-Ami, Zdeněk Ráčil, Vanessa Piechotta, Russell Lewis & Oliver A Cornely. (2022) Antifungal prophylaxis in adult patients with acute myeloid leukaemia treated with novel targeted therapies: a systematic review and expert consensus recommendation from the European Hematology Association. The Lancet Haematology 9:5, pages e361-e373.
Crossref
Crossref
Sang-Soo Park & Kwang-Hyun Baek. (2022) Acute Myeloid Leukemia-Related Proteins Modified by Ubiquitin and Ubiquitin-like Proteins. International Journal of Molecular Sciences 23:1, pages 514.
Crossref
Crossref